Most Read Articles
01 Oct 2020
In patients with major depressive disorder being treated with antidepressants, zinc supplementation contributes to a substantial reduction in depressive symptoms, a study has found.

E-cigarette use linked to poor mental health

Tristan Manalac
15 Oct 2020
To smoke or not to smoke: Whether e-cigarettes can be used as a mean to quit smoking is still in debates.

Stress and depressive moods appear to be heightened in people who use e-cigarettes, regardless of gender, according to a recent Korea study.

“Conventional cigarettes, which contain the addictive substance nicotine, are known to be highly related to mental health conditions (MHC), but research on e-cigarettes, which also often contain nicotine, is insufficient,” the researchers said. “The purpose of the study was to examine the association between e-cigarette use and MHC, focusing especially on stress status and elevated depressive symptoms among men and women of all ages.”

Drawing from the seventh cycle of the KNHANES*, data of 5,469 respondents were included in the present analysis. Five percent of the respondents were deemed to be at high risk of depression. Current smokers (p<0.001) and past users of e-cigarettes (p=0.001) were more predominant in the depressed subgroup. [Medicine 2020;9:e22514]

In both men and women, self-perceived high stress was highest among current smokers who had a history of e-cigarette use (40.1 percent and 54.5 percent, respectively). Analysis of variance revealed a significant between-group difference (p<0.001), as compared to smokers and nonsmokers who had never used a vape device.

Similarly, the prevalence of depressive mood was highest in smokers with prior e-cigarette use, both in men (4.9 percent; p=0.001) and women (27.3 percent; p<0.001). Mean scores on the Patient Health Questionnaires were likewise greatest in those who were current smokers and reported prior device use (p<0.001 for both men and women).

Multivariable logistic regression analysis confirmed that prior use of e-cigarettes was a significant risk factor for self-perceived high stress not only in smokers (odds ratio [OR], 1.83, 95 percent confidence interval [CI], 1.46–2.30; p<0.001) but also in nonsmokers (OR, 1.19, 95 percent CI, 1.03–1.36; p=0.016).

Similarly, smokers (OR, 2.08, 95 percent CI, 1.34–3.23; p=0.001) and nonsmokers (OR, 1.42, 95 percent CI, 1.08–1.85; p=0.011) who had used the device before were at a significantly greater risk of depressive mood. For both MHC outcomes, disaggregating according to sex only strengthened the effect of e-cigarette use on the risk estimates.

Though there remains no literature consensus, the researchers offered two potential mechanisms by which e-cigarettes may correlate with depressive moods.

“First, the substances contained in e-cigarettes contribute to this association,” they said, noting that “although e-cigarettes have manufacturer-related variations, like conventional cigarettes they usually contain the addictive substance nicotine, which is known to be highly correlated with depression.” [Tob Control 2014;23:77-78]

“Second, a depressive mood often results from trying to quit smoking and people often use e-cigarettes when attempting to quit smoking traditional cigarettes,” they added.

Further research is needed to better elucidate causal links, if any, the researchers said. “[L]ongitudinal studies should be conducted and include detailed information such as the duration, amount, and pattern of e-cigarette use.”

“Furthermore, social regulations regarding e-cigarettes, which are often perceived to be relatively safer than conventional cigarettes, must be established based on empirical research about the association between e-cigarettes and health outcomes,” they added.

*Korea National Health and Nutrition Examination Survey

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Psychiatry - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
01 Oct 2020
In patients with major depressive disorder being treated with antidepressants, zinc supplementation contributes to a substantial reduction in depressive symptoms, a study has found.